Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma
- PMID:7605996
Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma
Abstract
Epstein-Barr virus (EBV)-infected cells may sustain three distinct forms of virus latency. In lymphoblastoid cell lines, six EBV-encoded nuclear antigens (EBNA1, 2, 3A, 3B, 3C, -LP), three latent membrane proteins (LMP1, 2A, 2B), and two nuclear RNAs (EBERs) are expressed. This form of latency, termed latency III, is also encountered in some posttransplant lymphoproliferative disorders. In EBV-positive cases of Hodgkin's disease, the EBERs, EBNA1, and the LMPs are expressed (latency II), whereas in Burkitt's lymphoma (BL) only the EBERs and EBNA1 have been detected (latency I). We have studied the expression of EBV proteins in 17 cases of EBV-positive endemic BL by immunohistology. Expression of LMP1 was seen in variable proportions of tumor cells in two cases and EBNA2 was detected in some tumor cells in three other cases. Also, the BZLF1 trans-activator protein was expressed in a few tumor cells in 6 cases, indicating entry into the lytic cycle. A phenotypic drift from latency I to latency III has been observed previously in some BL cell lines. Our results suggest that a similar phenomenon may occur in BL in vivo and indicate that the operational definition of EBV latencies is not easily applied to human tumors.
Similar articles
- Expression of Epstein-Barr virus-gene products in Burkitt's lymphoma in Northeast Brazil.Araujo I, Foss HD, Bittencourt A, Hummel M, Demel G, Mendonca N, Herbst H, Stein H.Araujo I, et al.Blood. 1996 Jun 15;87(12):5279-86.Blood. 1996.PMID:8652843
- Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.Horenstein MG, Nador RG, Chadburn A, Hyjek EM, Inghirami G, Knowles DM, Cesarman E.Horenstein MG, et al.Blood. 1997 Aug 1;90(3):1186-91.Blood. 1997.PMID:9242551
- Expression of Epstein-Barr virus-encoded latent membrane protein 1 in nonendemic Burkitt's lymphomas.Carbone A, Gloghini A, Zagonel V, Tirelli U.Carbone A, et al.Blood. 1996 Feb 1;87(3):1202-4.Blood. 1996.PMID:8562951No abstract available.
- EBV-NK cells interactions and lymphoproliferative disorders.Kanegane H, Yachie A, Miyawaki T, Tosato G.Kanegane H, et al.Leuk Lymphoma. 1998 May;29(5-6):491-8. doi: 10.3109/10428199809050908.Leuk Lymphoma. 1998.PMID:9643562Review.
- EBNA2 and Its Coactivator EBNA-LP.Kempkes B, Ling PD.Kempkes B, et al.Curr Top Microbiol Immunol. 2015;391:35-59. doi: 10.1007/978-3-319-22834-1_2.Curr Top Microbiol Immunol. 2015.PMID:26428371Review.
Cited by
- The expression and function of Epstein-Barr virus encoded latent genes.Young LS, Dawson CW, Eliopoulos AG.Young LS, et al.Mol Pathol. 2000 Oct;53(5):238-47. doi: 10.1136/mp.53.5.238.Mol Pathol. 2000.PMID:11091847Free PMC article.Review.
- Epstein-Barr virus and Burkitt lymphoma.Brady G, MacArthur GJ, Farrell PJ.Brady G, et al.J Clin Pathol. 2007 Dec;60(12):1397-402. doi: 10.1136/jcp.2007.047977.J Clin Pathol. 2007.PMID:18042696Free PMC article.Review.
- Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.Sheu LF, Chen A, Wei YH, Ho KC, Cheng JY, Meng CL, Lee WH.Sheu LF, et al.Am J Pathol. 1998 Jan;152(1):63-74.Am J Pathol. 1998.PMID:9422524Free PMC article.
- Reframing Burkitt lymphoma: virology not epidemiology defines clinical variants.Rochford R.Rochford R.Ann Lymphoma. 2021 Sep;5:22. doi: 10.21037/aol-21-18. Epub 2021 Sep 30.Ann Lymphoma. 2021.PMID:34888589Free PMC article.
- Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features.Queiroga EM, Gualco G, Weiss LM, Dittmer DP, Araujo I, Klumb CE, Harrington WJ Jr, Bacchi CE.Queiroga EM, et al.Am J Clin Pathol. 2008 Dec;130(6):946-56. doi: 10.1309/AJCP64YOHAWLUMPK.Am J Clin Pathol. 2008.PMID:19019773Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources